1. Home
  2. SYBX vs GP Comparison

SYBX vs GP Comparison

Compare SYBX & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • GP
  • Stock Information
  • Founded
  • SYBX N/A
  • GP 2010
  • Country
  • SYBX United States
  • GP Canada
  • Employees
  • SYBX N/A
  • GP N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • SYBX Health Care
  • GP Consumer Discretionary
  • Exchange
  • SYBX Nasdaq
  • GP Nasdaq
  • Market Cap
  • SYBX 16.5M
  • GP 16.2M
  • IPO Year
  • SYBX N/A
  • GP 2020
  • Fundamental
  • Price
  • SYBX $1.20
  • GP $0.51
  • Analyst Decision
  • SYBX
  • GP Strong Buy
  • Analyst Count
  • SYBX 0
  • GP 2
  • Target Price
  • SYBX N/A
  • GP $2.33
  • AVG Volume (30 Days)
  • SYBX 6.3K
  • GP 78.5K
  • Earning Date
  • SYBX 03-06-2025
  • GP 02-14-2025
  • Dividend Yield
  • SYBX N/A
  • GP N/A
  • EPS Growth
  • SYBX N/A
  • GP N/A
  • EPS
  • SYBX N/A
  • GP N/A
  • Revenue
  • SYBX $8,000.00
  • GP $20,656,035.00
  • Revenue This Year
  • SYBX N/A
  • GP N/A
  • Revenue Next Year
  • SYBX N/A
  • GP $94.25
  • P/E Ratio
  • SYBX N/A
  • GP N/A
  • Revenue Growth
  • SYBX N/A
  • GP N/A
  • 52 Week Low
  • SYBX $1.15
  • GP $0.41
  • 52 Week High
  • SYBX $1.96
  • GP $1.91
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 34.47
  • GP 40.83
  • Support Level
  • SYBX $1.27
  • GP $0.41
  • Resistance Level
  • SYBX $1.32
  • GP $0.59
  • Average True Range (ATR)
  • SYBX 0.05
  • GP 0.05
  • MACD
  • SYBX -0.01
  • GP 0.00
  • Stochastic Oscillator
  • SYBX 17.81
  • GP 42.74

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: